Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 31

Trial Status

Completed1
Other1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT03069300Phase 3Unknown
N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis
Alcoholic HepatitisInfection
PrincipalinvestigatorStart date: 2015-10-01
NCT02496897Phase 1Completed
Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
Hepatitis B
PrincipalinvestigatorStart date: 2015-07-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Imperial College London

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT03069300Phase 3PrincipalInvestigator

N-ACetylcysteine to Reduce Infection and Mortality for Alcoholic Hepatitis

Alcoholic HepatitisInfection
Unknown
NCT02496897Phase 1PrincipalInvestigator

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Hepatitis B
Completed

All 2 trials loaded